Latest Health News

Brazilian Critical Minerals Ltd has been served with a writ alleging breach of a convertible loan agreement tied to share issuance and pricing, sparking a legal dispute with a US investment firm.

K&S Corporation has issued a cautious earnings update, forecasting a significant decline in underlying profit before tax for the first half of 2025 compared to last year.

Monadelphous Group Limited reported a robust FY25 with record contract wins and a 30% revenue surge, setting the stage for continued growth in FY26. The company’s strategic acquisitions and energy transition focus underpin its optimistic outlook.

HeraMED has inked a 12-month commercial agreement with Philips’ U.S. subsidiary to deliver an integrated digital maternity care platform to American hospitals, combining cutting-edge monitoring devices with HeraMED’s remote patient monitoring technology.

Australian Foundation Investment Company plans special fully franked dividends alongside its 2026 interim and final payouts, leveraging a strong franking credit balance.

Osteopore Limited has partnered with DKSH Malaysia in a five-year agreement to distribute its innovative dental products, aiming to capture significant growth in Malaysia’s guided bone regeneration sector.

SRG Global has landed $650 million worth of contracts spanning water, defence, energy, and more across Australia and New Zealand, reinforcing its position as a diversified infrastructure leader.

Bio-Gene Technology Limited has received a $519,500 R&D tax incentive from the Australian government, supporting its development of innovative bio-insecticides targeting insecticide resistance.

Euroz Hartleys Group Limited reported a robust FY2025 with an 87.7% jump in net profit and a strong start to FY2026, driven by increased brokerage and capital markets activity.

Pro Medicus Ltd has delivered a record-breaking FY2025 with revenue soaring nearly 32% and net profit up 39%, driven by landmark contracts and a robust growth pipeline.

Metro Performance Glass reported a surprising 157% jump in net profit for H1 2025, even as revenue fell 5%, raising questions about underlying business dynamics.

Island Pharmaceuticals has secured membership in the Medical Countermeasures Coalition, positioning its antiviral Galidesivir for critical US government stockpiling and regulatory milestones.